z-logo
open-access-imgOpen Access
Age at Diagnosis and Breast Cancer Survival in Iran
Author(s) -
Fatemeh Asadzadeh Vostakolaei,
Mireille J. M. Broeders,
Nematollah Rostami,
J.A.A.M. van Dijck,
Ton Feuth,
Lambertus A. Kiemeney,
André L. M. Verbeek
Publication year - 2012
Publication title -
international journal of breast cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.552
H-Index - 15
eISSN - 2090-3170
pISSN - 2090-3189
DOI - 10.1155/2012/517976
Subject(s) - breast cancer , medicine , estrogen receptor , stage (stratigraphy) , cancer , disease , oncology , young adult , gynecology , paleontology , biology
Background . Tumour characteristics are the most important prognostic factors in breast cancer. Patient-related factors such as young age at diagnosis, obesity, and smoking behaviour may also modify disease outcome. Due to the absence of a unique definition for “young age breast cancer” and the resulting variation in disease management, findings on the association between young age and prognosis of breast cancer are controversial. Methods . This study included 1500 patients with a primary diagnosis of breast cancer in six Iranian hospitals from 5 provinces. We modelled the relative excess risk (RER) of breast cancer death to age at diagnosis and tumour characteristics. Results . Excess risks of death were observed for stage IV disease and poorly differentiated tumours: RER of 4.3 (95% CI: 1.05–17.65) and 3.4 (95% CI: 1.17–9.87), respectively. “Older” patients, particularly those aged 50 and over, presented more often with advanced and poorly differentiated tumours ( P = 0.001). After adjustment for stage, histological grade, Her-2 expression, estrogen and progesterone receptors, and place of residency, breast cancer mortality was not significantly different across age groups. Conclusion . We conclude that there is no prognostic effect of age at diagnosis of breast cancer among breast cancer patients treated at cancer centres in different parts of Iran; young and relatively old women have similar risks of dying from breast cancer.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom